Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-04T17:00:27.052Z Has data issue: false hasContentIssue false

Antimicrobial use in food and companion animals

Published online by Cambridge University Press:  05 November 2008

John F. Prescott*
Affiliation:
Department of Pathobiology, University of Guelph, Guelph, Ontario N1G 2W1, Canada

Abstract

The vast literature on antimicrobial drug use in animals has expanded considerably recently as the antimicrobial resistance (AMR) crisis in human medicine leads to questions about all usage of antimicrobial drugs, including long-term usage in intensively managed food animals for growth promotion and disease prevention. Attention is also increasingly focusing on antimicrobial use and on bacterial resistance in companion animals, which are in intimate contact with the human population. They may share resistant bacteria with their owners, amplify resistant bacteria acquired from their owners, and act as a reservoir for human infection. Considerable effort is being made to describe the basis of AMR in bacterial pathogens of animals. Documentation of many aspects of use of antimicrobials in animals is, however, generally less developed and only a few countries can describe quantities of drugs used in animals to kg levels annually. In recent years, many national veterinary associations have produced ‘prudent use guidelines’ to try to improve antimicrobial drug use and decrease resistance, but the impact of guidelines is unknown. Within the evolving global movement for ‘antimicrobial stewardship’, there is considerable scope to improve many aspects of antimicrobial use in animals, including infection control and reduction of use, with a view to reducing resistance and its spread, and to preserving antimicrobial drugs for the future.

Type
Review Article
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aarestrup, FM (ed) (2006). Antimicrobial Resistance in Bacteria of Animal Origin. Washington: ASM Press.Google Scholar
Allerberger, F and Mittermayer, H (2008). Antimicrobial stewardship. Clinical Microbiology and Infection 14: 197199.CrossRefGoogle ScholarPubMed
Anderson, ME, Lefebvre, S and Weese, JS (2008). Evaluation of prevalence and risk factors for methicillin-resistant Staphylococcus aureus colonization in veterinary personnel attending an international equine veterinary conference. Veterinary Microbiology 129: 410417.CrossRefGoogle ScholarPubMed
Barlam, TF and DiVall, M (2006). Antibiotic-stewardship practices at top academic centers throughout the United States and at hospitals throughout Massachusetts. Infection Control and Hospital Epidemiology 27: 695703.CrossRefGoogle ScholarPubMed
Bywater, RJ and Caswell, MW (2000). An assessment of the impact of antibiotic resistance in different bacterial species and the contribution of animal sources to resistance in human infections. Journal of Antimicrobial Chemotherapy 46: 639645.CrossRefGoogle ScholarPubMed
Canadian Integrated Program for Antimicrobial Resistance Surveillance (2005). Available online at http://www.phac-aspc.gc.ca/cipars-picra/pdf/cipars-picra-2005_e.pdf.Google Scholar
Codex Alimentarius (2007). Joint FAO/WHO/OIE Expert Meeting on Critically Important Antimicrobials. Rome, Italy, 26–30 November. Available online at http://www.who.int/foodborne_disease/resources/Report%20joint%20CIA%20Meeting.pdf.Google Scholar
Collignon, P and Aarestrup, F (2007). Extended-spectrum β-lactamases, food, and cephalosporin use in food animals. Clinical Infectious Diseases 44: 13911392.CrossRefGoogle ScholarPubMed
Danish Antimicrobial Resistance Monitoring and Research Program (DANMAP) (2006). Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. Available online at http://www.danmap.org/pdfFiles/Danmap_2006.pdf.Google Scholar
Food and Drug Administration, Centre for Veterinary Medicine (2001). Risk Assessment on the Human Health Impact of Fluoroquinolone-Resistant Campylobacter Associated with the Consumption of Chicken. Available online at http://www.fda.gov/cvm/documents/revisedRA.pdf.Google Scholar
Giguère, S, Prescott, JF, Baggot, JD, Walker, RD and Dowling, PM (2006). Antimicrobial Therapy in Veterinary Medicine, 4th edn. Ames, IA: Blackwell Publishing.Google Scholar
Grave, K, Frøkjær, V, McEwen, S and Kruse, H (2006). Monitoring of antimicrobial drug usage in animals: methods and applications. In: Aarestrup, FM (ed.) Antimicrobial Resistance in Bacteria of Animal Origin. Washington: ASM Press, pp. 375395.Google Scholar
Guardabassi, L, Jensen, LB and Kruse, H (2008). Guide to Antimicrobial Drug Use in Animals. Oxford: Blackwell Publishing.CrossRefGoogle Scholar
Health Canada: Animal Uses of Antimicrobials and Impact on Resistance and Human Health (2002). Ottawa: Health Canada. Available online at http://www.hc-sc.gc.ca/dhp-mps/pubs/vet/amr-ram_final_report-rapport_06-27_cp-pc-eng.php.Google Scholar
Heuer, OE, Jensen, VF and Hammerum, AM (2005). Antimicrobial drug consumption in companion animals. Emerging Infectious Diseases 11: 344345.CrossRefGoogle ScholarPubMed
Institute of Medicine (1998). The Use of Drugs in Food Animals: Benefits and Risks. Washington: National Research Council.Google Scholar
Johnson, JR, Sannes, MR, Croy, C, Johnston, B, Clabots, C, Kuskowski, MA, Bender, J, Smith, KE, Winokur, PL and Belongia, EA (2007). Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnestoa and Wisconsin, 2002–2004. Emerging Infectious Diseases 13: 838846.CrossRefGoogle Scholar
Lees, P, Svendsen, O and Wiuff, C (2008). Strategies to minimize the impact of antimicrobial treatment on the selection of resistant bacteria. In: Guardabassi, L, Jensen, LB and Kruse, H (eds) Guide to Antimicrobial Drug Use in Animals. Oxford: Blackwell Publishing, pp. 77101.CrossRefGoogle Scholar
Leonard, FC and Markey, BK (2008). Methicillin-resistant Staphylococcus aureus in animals: a review. Veterinary Journal 175: 2736.CrossRefGoogle ScholarPubMed
Linton, AH (1977). Antibiotic resistance: the present situation reviewed. Veterinary Record 100: 354360.CrossRefGoogle ScholarPubMed
Morley, PS, Apley, MD, Besser, TE, Burney, DP, Fedorka-Cray, PJ, Papich, MG, Traub-Dargatz, JL and Weese, JS (2005). Antimicrobial drug use in veterinary medicine. Journal of Veterinary Internal Medicine 19: 617629.CrossRefGoogle ScholarPubMed
Pacala, S and Socolow, R (2004). Stabilization wedges: solving the climate problem for the next 50 years with current technologies. Science 305: 968972.CrossRefGoogle ScholarPubMed
Paskovaty, A, Pflomm, JM, Myke, N, and Seo, SK (2005). A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century. International Journal of Antimicrobial Agents 25: 110.CrossRefGoogle Scholar
Prescott, JF, Hanna, WJB, Reid-Smith, R, and Drost, K (2002). Antimicrobial drug use and resistance in dogs. Canadian Veterinary Journal 43: 107116.Google ScholarPubMed
Swedish Veterinary Antimicrobial Resistance Monitoring (SVARM) (2007). Available online at http://www.sva.se/en/Startpage/Engelsk-malgruppsnavigering/animalhealth/Antibiotic-Resistence/Monitoring-/SVARM-reports/.Google Scholar
Tollefson, L, Morris, D, Boland, C and Kay, J (2006). Licencing and approval of antimicrobials for use in animals. In: Aarestrup, FM (ed.) Antimicrobial Resistance in Bacteria of Animal Origin. Washington: ASM Press, pp. 361374.Google Scholar
Valois, AA, Endoh, YS, Grein, K and Tollefson, L (2008). Geographical differences in market availability, regulation and use of veterinary antimicrobial products. In: Guardabassi, L, Jensen, LB and Kruse, H (eds) Guide to Antimicrobial Drug Use in Animals. Oxford: Blackwell Publishing, pp. 5976.CrossRefGoogle Scholar
Weese, JS (2006). Prudent use of antimicrobials. In: Giguère, S, Prescott, JF, Baggot, JD, Walker, RD and Dowling, PM (eds) Antimicrobial Therapy in Veterinary Medicine, 4th edn. Ames, IA: Blackwell Publishing, pp. 437448.Google Scholar
World Health Organization (2001). Global Strategy for Containment of Antimicrobial Resistance. Switzerland: World Health Organization. Available online at http://www.who.int/csr/resources/publications/drugresist/WHO_CDS_CSR_DRS_2001_2_EN/en/.Google Scholar
World Health Organization (2002). Impacts of Antimicrobial Growth Promoter Termination in Denmark. Foulon, Denmark, 6–9 November. Available online at http://www.who.int/salmsurv/links/gssamrgrowthreportstory/en/.Google Scholar
World Health Organization (2003). Joint FAO/OIE/WHO Expert Workshop on Non-Human Antimicrobial Usage and Antimicrobial Resistance: Scientific Assessment. Geneva, Switzerland, 1–5 December. Available online at http://whqlibdoc.who.int/hq/2004/WHO_CDS_CPE_ZFK_2004.7.pdf.Google Scholar
World Health Organization (2004). Second Joint FAO/OIE/WHO Expert Workshop on Non-Human Antimicrobial Usage and Antimicrobial Resistance: Management Options. Oslo, Norway, 15–18 March. Available online at http://www.who.int/foodsafety/publications/micro/en/oslo_report.pdf.Google Scholar
World Health Organization (2005). Critically important antibacterial agents for human medicine for risk management strategies of non-human use: report of a WHO working group consultation, 15–18 February 2005, Canberra, Australia. Available online at http://www.who.int/foodborne_disease/resistance/FBD_CanberraAntibacterial_FEB2005.pdf.Google Scholar
World Health Organization (2007). Critically important antimicrobials for human medicine: categorization for the development of risk management strategies to contain antimicrobial resistance due to non-human antimicrobial use: report of the second WHO Expert Meeting, Copenhagen, 29–31 May 2007. Available online at http://www.who.int/foodborne_disease/resistance/antimicrobials_human.pdf.Google Scholar